Unlocking the Potential of ATAD3C: A novel Drug Target and Biomarker

Target Name: ATAD3C

NCBI ID: G219293

ATAD3C

Other Name(s): ATPase family, AAA domain containing 3A | ATPase family AAA domain containing 3C | ATD3C_HUMAN | ATPase family AAA domain-containing protein 3C

Unlocking the Potential of ATAD3C: A novel Drug Target and Biomarker

ATPase family, AAA domain containing 3A (ATAD3C) is a protein that plays a crucial role in various cellular processes. It is a key player in the transfer of ATP energy across cell membranes, which is essential for various cellular functions, including intracellular signaling, protein synthesis, and intracellular transport. The ATAD3C gene has been well-studied, and its function has been extensively characterized. In this article, we will explore the potential of ATAD3C as a drug target and biomarker.

Drug Target Potential

ATAD3C has been identified as a promising drug target due to its unique structure and its involvement in various cellular processes. The ATAD3C protein is a 120-kDa protein that contains an AAA domain, a conserved catalytic core, and a C-terminal hypervariable region (HVR). The AAA domain is known for its role in ATPase function, and the C-terminal HVR is involved in the protein's stability and interaction with other cellular components.

Several studies have shown that ATAD3C is involved in various cellular processes, including the transfer of ATP energy across cell membranes, protein synthesis, and intracellular transport. For example, ATAD3C has been shown to play a role in the transfer of ATP energy to the cytosol, which is involved in protein synthesis and various cellular processes. Additionally, ATAD3C has been shown to be involved in intracellular transport, specifically in the transport of nucleotides out of the cytosol and into the cell nucleus.

The potential of ATAD3C as a drug target is high due to its involvement in various cellular processes that are crucial for human health and disease. For example, various diseases are characterized by the misregulation of ATP energy transfer across cell membranes. These diseases include heart disease, neurodegenerative diseases, and cancer. Therefore, targeting ATAD3C with drugs that modulate its function could potentially lead to new treatments for these diseases.

Biomarker Potential

In addition to its potential as a drug target, ATAD3C has also been identified as a potential biomarker for various diseases. The ATAD3C protein is expressed in various tissues and cells, including heart muscle, brain, and cancer cells. Therefore, its levels can be used as a biomarker for various diseases, including heart disease, neurodegenerative diseases, and cancer.

Studies have shown that the expression of ATAD3C is affected by various factors, including stress, exercise, and disease. For example, stress has been shown to increase the expression of ATAD3C in heart muscle, while exercise has been shown to decrease its expression in heart muscle. Similarly, various diseases, including heart disease and cancer, have been shown to increase the expression of ATAD3C. Therefore, the expression of ATAD3C can be used as a biomarker for these diseases.

Conclusion

In conclusion, ATAD3C is a protein that plays a crucial role in various cellular processes, including the transfer of ATP energy across cell membranes and the regulation of intracellular signaling. Its function makes it an attractive drug target, and its expression is affected by various factors, including stress, exercise, and disease. Therefore, the potential of ATAD3C as a drug target and biomarker is high, and further studies are needed to fully understand its role in human health and disease.

Protein Name: ATPase Family AAA Domain Containing 3C

The "ATAD3C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATAD3C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets